Levels of SP‐A‐anti‐SP‐A immune complexes in neonatal respiratory distress syndrome correlate with subsequent development of bronchopulmonary dysplasia

A Comparison of Surfactant as Immediate Prophylaxis and as Rescue Therapy in Newborns of Less Than 30 Weeks' Gestation

1991 • 236 citations

Clinical and Roentgenographic Scoring Systems for Assessing Bronchopulmonary Dysplasia

1984 • 170 citations

Surfactant Protein A, Phosphatidylcholine, and Surfactant Inhibitors in Epithelial Lining Fluid: Correlation with Surface Activity, Severity of Respiratory Distress Syndrome, and Outcome in Small Premature Infants

1991 • 168 citations

Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants

1990 • 162 citations

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

1991 • 147 citations

Undernutrition as a Major Contributing Factor in the Pathogenesis of Bronchopulmonary Dysplasia

1988 • 129 citations

Predicting Risk for Bronchopulmonary Dysplasia: Selection Criteria for Clinical Trials

1990 • 128 citations

Respiratory distress syndrome treated with human surfactant: radiographic findings.

1985 • 76 citations

Potential Role of Eicosanoids and PAF in the Pathophysiology of Bronchopulmonary Dysplasia

1987 • 71 citations

Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia

1992 • 69 citations

Surfactant Proteins and Anti-Surfactant Antibodies in Sera from Infants With Respiratory Distress Syndrome With and Without Surfactant Treatment

1991 • 68 citations

Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome.

1986 • 60 citations

Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life

1992 • 58 citations

Failure to Detect Surfactant Protein-Specific Antibodies in Sera of Premature Infants Treated With Survanta, A Modified Bovine Surfactant

1991 • 46 citations

Immunogenicity and immunomodulatory activity of bovine surfactant (SF‐RI 1)

1992 • 40 citations

Occurrence, predictive factors and associated morbidity of broncho-pulmonary dysplasia in a preterm birth cohort

1988 • 30 citations

Human Surfactant Protein-A Contains Blood Group A Antigenic Determinants

1992 • 28 citations

Immunologic consequences of exogenous surfactant administration.

1988 • 28 citations

Antigenicity of low molecular weight surfactant species.

1989 • 16 citations

European multicenter trials of curosurf for treatment of neonatal respiratory distress syndrome

1990 • 12 citations

Surfactant as an immunogen: implications for therapy of respiratory distress syndrome

1992 • 5 citations

Immunogenicity of Surfactant and Its Implications for Replacement Therapy

1988 • 4 citations

Immunogenicity of Pulmonary Surfactant Preparations

1994 • 4 citations